Fritextsökning
Innehållstyper
-
Uncertainty about the government’s life science work
The government’s national coordinator for life science, Jenni Nordborg, left her position almost four months ago. No one has yet succeeded her, and now question...
-
Nanexa develops depot formulation of the diabetes and obesity drug Saxenda
Uppsala-based company Nanexa has signed an agreement with a German contract research company to start a clinical study with a monthly depot of liraglutide. The ...
-
19 medicines in Sweden are under investigation in a major EMA inquiry
unless new evidence can be provided that they are up to standard.
-
Förlikning i babypuderskandal stoppas av domstol
Det amerikanska läkemedelsbolaget Johnson & Johnson har för en andra gång fått avslag av en domare om en konkursansökan för dotterbolaget LTL Management, mest k...
-
Tougher competition as the Novo Nordisk Foundation broadens its programme
Søren Nedergaard has worked with innovation at the Danish Government Offices and the University of Copenhagen. Today, he is COO of the Novo Nordisk Foundation, ...
-
Larm om vaccinbrist efter utbrott av difteri i Västafrika
Ett allvarligt utbrott av difteri har drabbat Västafrika. Nu varnar Läkare utan gränser för brist på läkemedel och vaccin mot sjukdomen.
-
New drug alert in the US: Rise in overdoses linked to the use of drugs for animals
A combination of the synthetic drugs fentanyl and xylazine, an animal tranquilizer, has been labelled a “growing threat” by the White House due to its role in t...
-
Bioarctic granted Japanese patent for Parkinson’s disease candidate
Bioarctic has been granted a Japanese patent for its antibodies targeting Parkinson’s disease.
-
Swedish and Ukrainian Medical Product Agencies sign an agreement
The Directors-General of the Swedish and Ukrainian Medical Products Agencies have signed a cooperation agreement.
-
Biosimilars bring price pressure, but are they sufficiently used?
When biosimilars were introduced just over 16 years ago, hopes were raised that they would give many more patients access to effective but otherwise extremely e...
-
Branschen om nya strategin – efterlyser konkretisering
Regeringens uppdaterade life science-strategi får beröm av branschen för sin ambitionsnivå när det gäller förbättrad konkurrenskraft, men samtidigt efterlyses k...
-
Tablet treatment for hair loss approved in the USA
The US Drug Administration has given a thumbs up for the first tablet treatment for spotty hair loss.
-
The fast route to a safe insulin pen
Diabetes is on the rise worldwide with around ten million people developing the disease every year. Demand for insulin pens allowing patients to self-medicate i...
-
Mathias Uhlén’s protein atlas is recognised as a global resource
The Human Protein Atlas is the first database in Sweden to be designated a Global Core Biodata Resource. According to Mathias Uhlén, this is a quality hallmark ...
-
Anna Törner: ”Orphan Designation – the "petite robe noire" of drug development”
It is easy to cling to various regulatory incentives, like orphan designation, and other expedited pathways, without understanding what they truly mean or wheth...
-
Suing the company – for NOT developing a new HIV drug
Was Gilead putting a steady flow of profits from its cash cow ahead of developing a new and safer drug? According to a large number of US HIV patients in a lega...
-
Gothenburg-based company acquired by Norwegian diagnostics group
Gentian Diagnostics acquires Gothenburg-based Getica.
-
Julefrid ger läsetid – 10 artikeltips från redaktionen
När julstöket är avklarat, magen fått sitt och släkten avlägsnat sig lägger sig den stora friden – och kanske vaknar läslusten?
-
Björn Arvidsson: ”Långsiktiga satsningar är inga lyxprojekt utan framtidslöften”
Life science kan bli Sveriges nästa stora kapitel, men för det krävs uthållighet och politiskt mod, skriver Björn Arvidsson i en krönika.
-
Björn Arvidsson: “We need robust and recognized ecosystems for continued competitiveness”
“We have idea carriers and excellent innovation opportunities, and now we must invest in creating ecosystems that provide them with even better growth opportuni...
-
Vårdrepresentanter hoppas på större statligt ansvar nästa mandatperiod
Valnatten blev en rysare och idag, måndag, är utgången fortfarande oviss med en fördel för högerblocket med en mandat.
-
Tyska Biontech storsatsar i Storbritannien
Den tyska vaccin- och läkemedelsutvecklaren Biontech ska investera upp till en miljard pund, motsvarande nästan 13 miljarder kronor, på att utveckla sin forskni...
-
Delseger i domstol för entreprenör som miste sitt bolag
Life science-profilen Mikael Kubista har vunnit rond 1 mot en advokatfirma som han tillsammans med andra delägare stämt för vårdslös rådgivning i samband med at...
-
Just four weeks to a concept for an emergency ventilator
The lockdown in spring 2020 meant that the majority of Festo employees had to join the ranks of those working from home. Yet within the space of just four weeks...
BREAKING